CMV retinitis: Difference between revisions
Ostermayer (talk | contribs) (Text replacement - "Category:Ophtho" to "Category:Ophthalmology") |
ClaireLewis (talk | contribs) |
||
(8 intermediate revisions by 4 users not shown) | |||
Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Most frequent and serious ocular opportunistic infection | *Most frequent and serious ocular opportunistic infection | ||
*Leading cause of blindness in AIDS | *Leading cause of blindness in [[AIDS]] patients | ||
*Typically occurs with CD4 less than 50 | *Typically occurs with CD4 less than 50 | ||
Line 8: | Line 8: | ||
==Clinical Features== | ==Clinical Features== | ||
*Variable, but may include: | *Variable, but may include: | ||
**Change in visual acuity | **Change in visual acuity, [[visual loss]] | ||
**Visual field cuts (Scotomas, loss of central vision) | **[[visual field defects|Visual field cuts]] (Scotomas, loss of central vision) | ||
**Floaters, flashing lights | **[[Floaters]], flashing lights | ||
**Photophobia | **Photophobia | ||
**Eye redness | *[[Fundoscopy]]: | ||
**Fluffy white perivascular lesions | |||
**Dirty white granular retinal necrosis | |||
**Adjacent hemorrhage - "Pizza pie" appearance | |||
**[[Eye pain]]/[[red eye|redness]] | |||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
Line 19: | Line 24: | ||
{{HIV associated conditions}} | {{HIV associated conditions}} | ||
== | ==Evaluation== | ||
*CD4 typically < 50 cells/mm³ | *CD4 typically < 50 cells/mm³ | ||
==Management== | ==Management== | ||
Line 31: | Line 32: | ||
==Complications== | ==Complications== | ||
*Retinal detachment | *[[Retinal detachment]] | ||
*Complete | *Complete [[vision loss]] | ||
**Despite treatment, 10% lose vision | |||
*CMV Immune Recovery Uveitis (IRU) | *CMV Immune Recovery Uveitis (IRU) | ||
**Patients with retinitis who develop blurry vision after starting | **Patients with retinitis who develop blurry vision after starting HAART need ophtho eval to assess for CMV progression, relapse, or IRU | ||
**Possible cause - T-cell mediated immune reconstitution to latent CMV intraocular antigens | **Possible cause - T-cell mediated immune reconstitution to latent CMV intraocular antigens | ||
**Symptoms - Floaters, photophobia, blurred vision | **Symptoms - Floaters, photophobia, blurred vision | ||
Line 41: | Line 43: | ||
==Disposition== | ==Disposition== | ||
==See Also== | ==See Also== |
Revision as of 21:46, 6 October 2019
Background
- Most frequent and serious ocular opportunistic infection
- Leading cause of blindness in AIDS patients
- Typically occurs with CD4 less than 50
Clinical Features
- Variable, but may include:
- Change in visual acuity, visual loss
- Visual field cuts (Scotomas, loss of central vision)
- Floaters, flashing lights
- Photophobia
- Fundoscopy:
- Fluffy white perivascular lesions
- Dirty white granular retinal necrosis
- Adjacent hemorrhage - "Pizza pie" appearance
Differential Diagnosis
Acute onset flashers and floaters
- Ocular causes
- Floaters and/or flashes
- Posterior vitreous detachment
- Retinal tear or retinal detachment
- Posterior uveitis
- Predominantly floaters
- Vitreous hemorrhage secondary to proliferative retinopathy
- Sympathetic ophthalmia
- Predominantly flashes
- Oculodigital stimulation
- Rapid eye movements
- Neovascular age-related macular degeneration
- Floaters and/or flashes
- Nonocular causes
- Migraine aura (classic)
- Migraine aura (acephalgicmigraine)
- Occipital lobe disorders
- Postural hypotension
HIV associated conditions
- HIV neurologic complications
- HIV pulmonary complications
- Ophthalmologic complications
- Other
- HAART medication side effects[1]
- HAART-induced lactic acidosis
- Neuropyschiatric effects
- Hepatic toxicity
- Renal toxicity
- Steven-Johnson's
- Cytopenias
- GI symptoms
- Endocrine abnormalities
Evaluation
- CD4 typically < 50 cells/mm³
Management
Antivirals
Severe Vision Threatening
- Ganciclovir intraocular implant for 8 months AND
- Valganciclovir 900mg PO q12hrs x 14 days FOLLOWED BY 900mg PO q24hrs x 7 days
Peripheral lesions
- Valganciclovir 900mg PO q12hrs x 21 days FOLLOWED BY 900mg PO q24hrs x 7 days
Complications
- Retinal detachment
- Complete vision loss
- Despite treatment, 10% lose vision
- CMV Immune Recovery Uveitis (IRU)
- Patients with retinitis who develop blurry vision after starting HAART need ophtho eval to assess for CMV progression, relapse, or IRU
- Possible cause - T-cell mediated immune reconstitution to latent CMV intraocular antigens
- Symptoms - Floaters, photophobia, blurred vision
- Occurs median 20 weeks after starting HAART
- Urgent ophtho eval
Disposition
See Also
References
- ↑ Gutteridge, David L MD, MPH, Egan, Daniel J. MD. The HIV-Infected Adult Patient in The Emergency Department: The Changing Landscape of the Disease. Emergency Medicine Practice: An Evidence-Based Approach to Emergency Medicine. Vol 18, Num 2. Feb 2016.
- Rothmans RE, Marco CA, Yang S. Human immunodeficiency virus infection and acquired immunodeficiency syndrome, in Tintinalli JE, Stapczynski JS, Ma OJ, et al (eds): Tintinalli’s Emergency Medicine, ed 7. New York, The McGraw-Hill Companies Inc., 2011.